West Pharmaceutical Services (WST) Leases (2016 - 2025)
Historic Leases for West Pharmaceutical Services (WST) over the last 13 years, with Q4 2025 value amounting to $117.0 million.
- West Pharmaceutical Services' Leases rose 1196.17% to $117.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $117.0 million, marking a year-over-year increase of 1196.17%. This contributed to the annual value of $117.0 million for FY2025, which is 1196.17% up from last year.
- Latest data reveals that West Pharmaceutical Services reported Leases of $117.0 million as of Q4 2025, which was up 1196.17% from $97.8 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Leases registered a high of $117.0 million during Q4 2025, and its lowest value of $58.5 million during Q3 2021.
- Moreover, its 5-year median value for Leases was $98.5 million (2023), whereas its average is $91.9 million.
- In the last 5 years, West Pharmaceutical Services' Leases tumbled by 1333.33% in 2021 and then surged by 5064.94% in 2022.
- Over the past 5 years, West Pharmaceutical Services' Leases (Quarter) stood at $69.3 million in 2021, then skyrocketed by 50.65% to $104.4 million in 2022, then decreased by 4.98% to $99.2 million in 2023, then rose by 5.34% to $104.5 million in 2024, then rose by 11.96% to $117.0 million in 2025.
- Its Leases stands at $117.0 million for Q4 2025, versus $97.8 million for Q3 2025 and $104.4 million for Q2 2025.